Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

US authorization of first COVID vaccine marks new phase in safety monitoring

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Prices may be subject to local taxes which are calculated during checkout

Nature 588, 377-378 (2020)

doi: https://doi.org/10.1038/d41586-020-03542-4

Updates & Corrections

  • Update 12 December 2020: On 12 December, the story was updated with the US FDA's decision to issue an emergency use authorization for the Pfizer–BioNTech vaccine.

References

  1. Polack, F. P. et al. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2034577 (2020).

    Article  PubMed  Google Scholar 

Download references

Subjects

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links